TY - JOUR
T1 - Routine loneliness screening in adults with atherosclerotic cardiovascular disease in a large national health plan
T2 - a retrospective cohort study
AU - Galper, Kathleen
AU - Nudy, Matthew
AU - Sinoway, Lawrence
AU - Brignone, Emily
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/10/2
Y1 - 2025/10/2
N2 - Objectives To investigate the association between loneliness and all-cause mortality and inpatient hospitalisation among adults with atherosclerotic cardiovascular disease (ASCVD) in a real-world setting, and to explore the potential implications of routine loneliness screening. The primary hypothesis was that loneliness is associated with increased all-cause mortality. Design Observational retrospective cohort study. Setting Analysis of linked administrative claims and routinely collected loneliness screening data from a large health plan. Participants 7484 adult health plan members with documented ASCVD and ≥10 months of continuous enrolment around the screening date. Selection criteria included ASCVD diagnosis and sufficient enrolment for baseline assessment. Primary and secondary outcome measures The primary outcome measure was 365-day all-cause mortality. The secondary outcome measure was the 365-day all-cause inpatient hospitalisation rate. Results 881 deaths occurred during follow-up (18% in the lonely group vs 11% in the non-lonely group). The lonely group had a lower proportion of men (54% vs 65%, p<0.01) and a slightly older mean age (68.4 (SD 12.7) vs 67.5 (SD 12.6), p<0.05) compared with the non-lonely group. Among the lonely, adjusted survival models showed a statistically significant 33% increase in all-cause relative mortality risk, which is a 3% absolute increase in mortality (HR 1.33, 95%CI 1.10 to 1.62). Adjusted Poisson models indicated a similar statistically significant increase in inpatient stays of 17 per 1000 person-years among the lonely, reflecting a 39% relative increase in risk (incidence rate ratio 1.39, 95%CI 1.16 to 1.66). Conclusions Our findings corroborate the association between loneliness and morbidity and mortality among those with known ASCVD. The effect for loneliness was similar in magnitude to clinical comorbidities and smoking, suggesting that routine screening for loneliness may provide valuable information for assessing and managing the risk of death among patients with ASCVD.
AB - Objectives To investigate the association between loneliness and all-cause mortality and inpatient hospitalisation among adults with atherosclerotic cardiovascular disease (ASCVD) in a real-world setting, and to explore the potential implications of routine loneliness screening. The primary hypothesis was that loneliness is associated with increased all-cause mortality. Design Observational retrospective cohort study. Setting Analysis of linked administrative claims and routinely collected loneliness screening data from a large health plan. Participants 7484 adult health plan members with documented ASCVD and ≥10 months of continuous enrolment around the screening date. Selection criteria included ASCVD diagnosis and sufficient enrolment for baseline assessment. Primary and secondary outcome measures The primary outcome measure was 365-day all-cause mortality. The secondary outcome measure was the 365-day all-cause inpatient hospitalisation rate. Results 881 deaths occurred during follow-up (18% in the lonely group vs 11% in the non-lonely group). The lonely group had a lower proportion of men (54% vs 65%, p<0.01) and a slightly older mean age (68.4 (SD 12.7) vs 67.5 (SD 12.6), p<0.05) compared with the non-lonely group. Among the lonely, adjusted survival models showed a statistically significant 33% increase in all-cause relative mortality risk, which is a 3% absolute increase in mortality (HR 1.33, 95%CI 1.10 to 1.62). Adjusted Poisson models indicated a similar statistically significant increase in inpatient stays of 17 per 1000 person-years among the lonely, reflecting a 39% relative increase in risk (incidence rate ratio 1.39, 95%CI 1.16 to 1.66). Conclusions Our findings corroborate the association between loneliness and morbidity and mortality among those with known ASCVD. The effect for loneliness was similar in magnitude to clinical comorbidities and smoking, suggesting that routine screening for loneliness may provide valuable information for assessing and managing the risk of death among patients with ASCVD.
UR - https://www.scopus.com/pages/publications/105017579063
UR - https://www.scopus.com/pages/publications/105017579063#tab=citedBy
U2 - 10.1136/bmjopen-2025-103542
DO - 10.1136/bmjopen-2025-103542
M3 - Article
C2 - 41043827
AN - SCOPUS:105017579063
SN - 2044-6055
VL - 15
JO - BMJ open
JF - BMJ open
IS - 10
M1 - e103542
ER -